← Back to Browse
ProductMedical Services and Publications

NGS (Next-Generation Sequencing) Service

Seoul, South Korea

High-throughput DNA sequencing service for comprehensive genomic analysis. Integrated component of the GeneCker cancer diagnosis platform for mutation identification and characterization.

Manufactured by

GeneCker Co., Ltd.

Seoul, South Korea

GeneCker is a biotechnology company specializing in ultra-precision CRISPR technology and the MUTE-Seq® platform—an ultrasensitive liquid-biopsy NGS solution. From research and development to kit manufacturing, we provide an end-to-end service for advanced cancer genomics. Our flagship CRISPincette MultiCancer kit incorporates both our patented MUTE-Seq® and CRISPR Cas9 technologies to enrich variant-containing DNA fragments for accurate multi-cancer risk assessment. With operations in Korea, China, and other global markets, GeneCker delivers solutions for Multi-Cancer Early Detection (MCED) and Minimal Residual Disease (MRD) monitoring at ~20× higher analytical precision and one-tenth the per-sample cost compared to conventional UMI-based NGS.

View profile & products →

✦ Product-Specific Coverage

AI supplier coverage for this product

Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.

Generated for this product

AI-matched supplier coverage based on related product alternatives.

0
Relevant manufacturers
matched to this product
0
Relevant products analyzed
for supplier coverage
0
Sourcing countries
identified

AI-Matched Alternative Products

from other manufacturers

AI-Matched Alternative Products

from other manufacturers

3 of 14 closest product alternatives

14 products

11 more product alternatives available

Create a free account to compare more product alternatives and supplier options.

Get Free Access →

© 2026 Suplivia · Home · Browse Products